Company: BIAF
Filing Date: 2025-06-27
Form Type: POS AM
Source: 0001641172-25-016927
Chunk: 73

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-27
Form: POS AM
Chunk 73
---
 agreed to exercise for cash March 2024 Common Warrants to purchase up to an aggregate of 1,041,667 shares of Common Stock, at the lower exercise price of $1.25 per share (reduced from the initial exercise price of $1.64 per share). The offer and resale of the shares of Common Stock underlying the March 2024 Common Warrants was registered pursuant to our registration statement Form S-1 (File No. 333-278512).

The transactions contemplated by the August Inducement Agreement closed on August 5, 2024. We received aggregate gross proceeds of approximately $1.3 million for the exercise of the March 2024 Common Warrants, before deducting placement agent fees and other expenses payable by us.

In consideration of the immediate exercise of March 2024 Common Warrants to purchase an aggregate of 1,041,667 shares of Common Stock by the Warrant Inducement Holders (the “Warrant Inducement”), at the exercise price of $1.25 per share, in accordance with the August Inducement Agreement, we issued to such holders new warrants to purchase an aggregate of 1,302,082 shares of Common Stock, equal to 125% of the number of shares of Common Stock issued in connection with the Warrant Inducement, at an exercise price of $1.50 per share. The issuance of the Inducement Warrants and the shares of Common Stock issuable upon exercise of the Inducement Warrants (the “Inducement Warrant Shares”) were not registered under the Securities Act.

We agreed in the August Inducement Agreement to file a registration statement on Form S-1 to register the resale of the Inducement Warrant Shares as soon as practicable (and in any event within 45 calendar days following the date of the August Inducement Agreement) and to use commercially reasonable efforts to have such registration statement effective at all times until no Inducement Warrant Holder owns any Inducement Warrants or Inducement Warrant Shares. On September 11, 2024, we filed the September 2024 Registration Statement (Registration No. 333-282045), registering the resale of the Inducement Warrant Shares, which was subsequently declared effective by the SEC on September 19, 2024. The September 2024 Registration Statement also registers the resale of the shares of Common Stock issuable upon exercise of the Inducement Advisor Warrants.

Wallach